Company profile
Dompé
We Embrace the Challenge in Science
- Industry
- Pharmaceutical Manufacturing
- Employees
- 1,154
- Headquarters
- Milano, Lombardia
- LinkedIn followers
- 189,488
- Office locations
- 7
Dompé company summary
Dompé is a company in the Pharmaceutical Manufacturing industry, headquartered in Milano, Lombardia. On LinkedIn the company has around 1,154 employees and 189,488 followers. The company lists 7 office locations. Its listed specialties include Pharmaceuticals, Biotechnology, Research and Development, Innovation, Primary Care.
What technology does Dompé use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Dompé
Dompé is a private, family-owned biopharmaceutical company with more than 130 years of independent history, focused on redefining treatments for ophthalmic, neurological, and pain-related conditions through breakthrough science. As the first company to unlock the therapeutic potential of nerve growth factor (NGF), Dompé is advancing first-in-class, disease-modifying therapies that target the underlying causes of nerve damage rather than symptoms alone. Building on Nobel Prize-winning science, our work has already led to the approval of the first topical biologic in ophthalmology for a rare neurotrophic eye disease, and continues to expand into high-unmet-need areas across eye, brain, and pain indications. Our research and development model combines scientific rigor with agility. Our curiosity-driven R&D team follows the science where it leads - developing innovative biologics, advancing multiple clinical programs, and exploring new delivery platforms - to address complex and hard-to-treat diseases. Independence is central to who we are. It enables long-term thinking, sustained investment in innovation, and the ability to integrate research, manufacturing, and commercialization with the discipline of an established pharmaceutical company and the speed of a biotech. Beyond science, Dompé is deeply committed to patients, access to care, and the next generation of scientific leaders—through patient support programs and long-standing investments in education and talent development. Our mission is clear: to bring the full potential of NGF and other breakthrough molecules to patients, and in doing so, transform how diseases of the nervous system are treated.
Specialties
Where is Dompé located?
Dompé lists 7 office locations.
Compare companies similar to Dompé
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Dompé dompe.com | Pharmaceutical Manufacturing | 1,154 | - | Milano, Lombardia |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about Dompé
What does Dompé do?
Dompé is a private, family-owned biopharmaceutical company with more than 130 years of independent history, focused on redefining treatments for ophthalmic, neurological, and pain-related conditions through breakthrough science. As the first company to unlock the therapeutic potential of nerve growth factor (NGF), Dompé is advancing first-in-class, disease-modifying therapies that target the underlying causes of nerve damage rather than symptoms alone. Building on Nobel Prize-winning science, our work has already led to the approval of the first topical biologic in ophthalmology for a rare neurotrophic eye disease, and continues to expand into high-unmet-need areas across eye, brain, and pain indications. Our research and development model combines scientific rigor with agility. Our curiosity-driven R&D team follows the science where it leads - developing innovative biologics, advancing multiple clinical programs, and exploring new delivery platforms - to address complex and hard-to-treat diseases. Independence is central to who we are. It enables long-term thinking, sustained investment in innovation, and the ability to integrate research, manufacturing, and commercialization with the discipline of an established pharmaceutical company and the speed of a biotech. Beyond science, Dompé is deeply committed to patients, access to care, and the next generation of scientific leaders—through patient support programs and long-standing investments in education and talent development. Our mission is clear: to bring the full potential of NGF and other breakthrough molecules to patients, and in doing so, transform how diseases of the nervous system are treated.
How many employees does Dompé have?
Dompé has around 1,154 employees on LinkedIn.
Where is Dompé headquartered?
Dompé is headquartered in Milano, Lombardia.
Where does Dompé have offices?
Dompé lists 7 office locations, including Milano, Lombardia, IT; Boston, Massachusetts, US; L'Aquila, AQ, IT; Naples, Campania, IT; San Mateo, California, US.
Build a lead list from companies like Dompé
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.